Cutaneous manifestations of tuberous sclerosis

Ochsner Journal

Volumn 10, Issue 3, 2010, Pages 200-204

  Hake, Sue ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Feet; Fibroma; Subungual; Tuberous sclerosis

Indexed keywords

ADULT; BONE CYST; BONE RADIOGRAPHY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBROMA; HALLUX VALGUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PHYSICAL EXAMINATION; REVIEW; SKIN DEFECT; TUBEROUS SCLEROSIS; TUMOR VOLUME;

EID: 77957334628     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Schwartz RA, Fernández G, Kotulska K, Jóźwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol. 2007;57(2):189-202.
2. Jozwiak J, Jozwiak S, Wlodarski P. Possible mechanism of disease development in tuberous sclerosis. Lancet Oncol. 2008;9(1):73-79.
3. Kandt RS. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases. Neurol Clin. 2002;20(4):941-964.
4. Berlin AL, Billick RC. Use of CO2 laser in the treatment of periungual fibromas associated with tuberous sclerosis. Dermatol Surg. 2002;28(5):434-436.
5. Mazaira M, del Pozo Losada J, Fernández-Jorge B, Fernández-Torres R, Martínez W, Fonseca E. Shave and phenolization of periungual fibromas, Koenen's tumors, in a patient with tuberous sclerosis. Dermatol Surg. 2007;34(1):111-113.
6. Iscan A, Kurul S, Dirik E. Clinical findings in tuberous sclerosis in Turkish children. J Pediatr Neurol. 2005;3(2): 95-102.
7. Schnur RE. Tuberous sclerosis: the persistent challenge of clinical diagnosis. Arch Dermatol. 1995;131(12):1460-1462.
8. Kwiatkowski DJ, Short MP. Tuberous sclerosis. Arch ermatol. 1994;130(3):348-354.
9. Harris-Smith R, Elston DM. Tuberous sclerosis. Cutis. 2002;69:103-169.
10. Tashiro M, Hirose W, Hanabusa H, et al. Pancytopenia in tuberous sclerosis. Med Sci Monit. 2001;7(3):444-447.
11. Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D, Hawley L. Diagnostic criteria: tuberous sclerosis complex- report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association. J Child Neurol. 1992;7(2): 221-224.
12. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13(12):624-628.
13. Danden JW, Teeslink R, Parrish A. Hamartoma of the spleen: a manifestation of tuberous sclerosis. Am Surg. 1975;41(9):564-566.
14. Ruiz-Villaverde R, Blasco-Melguizo J, Herná ndez-Jurado I, Naranjo-Sintes R, Gutierrez Salmeró n MT. Bilateral and multiple periungual fibromas as an oligosymptomatic form of tuberous sclerosis. Dermatology. 2004;209(2):160-161.
15. Feinstein MH. Foot pathology associated with tuberous sclerosis and neurofibromatosis. J Am Podiatry Assoc. 1972;62(9):336-350.
16. Webb D, Osborne JP. Tuberous sclerosis. Arch Dis hild. 1995;72:471-474.
17. Baran R, Richert B. Common nail tumors. Dermatol Clin. 2006;24(3):297-311.
18. Aste N, Pau M, Aste N, Biggio P. Tuberous sclerosis with unusual giant ungual fibromas. J Eur Acad Dermatol Venereol. 2003;17(1):100-101.
19. Radó JP, Haris A. Metabolic bone disease (anticonvulsant osteomalacia) and renal tubular acidosis in tuberous sclerosis. Intern Med. 1993;32(7):574-579.
20. Ward PE, McCarthy DJ. Periungual fibroma. Cutis. 1990;46:118-124.
21. Lee N, Woodrum CL, Nobil AM, Rauktys AE, Messina MP, Dabora SL. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models. BMC Pharmacol. 2009;9:8.
22. Sampson JR. Therapeutic targeting of mTOR in tuberous sclerosis. Biochem Soc Trans. 2009;37(pt 1):259-264.